Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease

Archives of Virology

Volumn 144, Issue 7, 1999, Pages 1299-1308

  Takahashi, K ^a   Ohta, Y ^a   Kanai, K ^a   Akahane, Y ^b   Iwasa, Y ^b   Hino, K ^c   Ohno, N ^d   Yoshizawa, H ^e   Mishiro, S ^a  

^a Shinagawa ku   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c Hepatitis Research Institute   (Japan)

^d Ohno Gastroenterology Clinic   (Japan)

^e HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LIVER DISEASE; GENOME ANALYSIS; GENOTYPE; HEPATITIS B VIRUS; LIVER CELL CARCINOMA; MUTATION; VIRAL GENETICS;

BASE SEQUENCE; CHRONIC DISEASE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032788282     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050588     Document Type: Article

References (21)

1. 1. Brunetto MR, Stemler M, Schodel F, Will H, Ottobrelli A, Rizzetto M, Verme G, Bonino F (1989) Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 21: 151-154
2. 2. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii: 588-591
3. 3. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325-329
4. 4. Harison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ (1991) Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 13: S105-107
5. 5. Kaneko M, Uchida T, Moriyama M, Arakawa Y, Shikata T, Gotoh K, Mima S (1995) Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol 47: 204-208
6. 6. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E (1991) A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324: 1705-1709
7. 7. Lo W-Y, Ting L-P (1994) Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome. J Virol 68: 1758-1764
8. 8. Nagasaka A, Hige S, Marutani M, Tsunematsu T, Saito M, Yamamoto Y, Konishi S, Asaka M (1998) Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection. Dig Dis Sci 43: 2473-2478
9. 9. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequencing: comparison of surface antigen subtypes. J Gen Virol 69: 2575-2585
10. 10. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M (1990) Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64: 1298-1303
11. 11. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M (1994) Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68: 8102-8110
12. 12. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M (1991) Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324: 1699-1704
13. 13. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, Tsuda F, Tanaka T, Okamoto H, Miyakawa Y, Mayumi M (1995) Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 122: 241-248
14. 14. Stemler M, Weimer T, Tu Z-X, Wan D-F, Levrero M, Jung C, Pape GR, Will H (1990) Mapping of B-cell epitopes of the hepatitis B virus X protein. J Virol 64: 2802-2809
15. 1764) of hepatitis B virus: clinical implications and an easy method for detection. J Gen Virol 76: 3159-3164
16. 16. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S (1998) Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 143: 2313-2326
17. 17. Uchida T, Saitoh T, Shinzawa H (1997) Mutations of the X region of hepatitis B virus and their clinical implications. Pathol Int 47: 183-193
18. 18. Wang Y, Chen P, Wu S, Sun AL, Wang H, Zhu YA, Li ZP (1990) A new enhancer element, ENII, identified in the X gene of hepatitis B virus, J Virol 64: 3977-3981
19. 19. Yuh C-H, Ting L-P (1990) The genome of the hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol 64: 4281-4287
20. 20. Yuh CH, Chang YL, Ting LP (1992) Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66: 4073-4084
21. 21. Williams JS, Andrisani OM (1995) The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci USA 92: 3819-3823